Abstract
Fourteen patients with uraemic anaemia and having regular haemodialysis were given human recombinant erythropoietin in increasing doses, beginning with 24 U/kg thrice weekly. One patient was dropped from the study because of recurrent thrombosis of vascular access sites. In the other 13 patients, followed up for a mean of 9.1 months (range 8-11), haemoglobin concentrations increased from 62 (SD 8) to 105 (9) g/l. No antierythropoietin antibodies were detected during the study. The correction of anaemia was associated with a tendency to hyperkalaemia and a mild increase of unconjugated bilirubinaemia. In eight previously hypertensive patients antihypertensive treatment had to be reinforced, but in normotensive patients blood pressure did not change. Thrombosis of arteriovenous fistulas occurred in two patients and a cerebral ischaemic lesion in one. Protracted treatment with human recombinant erythropoietin evidently can maintain normal haemoglobin concentrations in uraemic patients over time. Full correction of anaemia, however, may trigger some vascular problems, particularly in hypertensive patients and those with a tendency to thromboembolism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adamson J. W., Eschbach J., Finch C. A. The kidney and erythropoiesis. Am J Med. 1968 May;44(5):725–733. doi: 10.1016/0002-9343(68)90254-4. [DOI] [PubMed] [Google Scholar]
- Coleman T. G., Neff M. S. Hemodynamics of uremic anemia. Circulation. 1972 Feb;45(2):510–511. doi: 10.1161/01.cir.45.2.510. [DOI] [PubMed] [Google Scholar]
- Egrie J. C., Cotes P. M., Lane J., Gaines Das R. E., Tam R. C. Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods. 1987 May 20;99(2):235–241. doi: 10.1016/0022-1759(87)90133-5. [DOI] [PubMed] [Google Scholar]
- Elwood P. C., Waters W. E., Benjamin I. T., Sweetnam P. M. Mortality and anaemia in women. Lancet. 1974 May 11;1(7863):891–894. doi: 10.1016/s0140-6736(74)90346-8. [DOI] [PubMed] [Google Scholar]
- Gorsky J. E., Dietz A. A. Determination of aluminum in biological samples by atomic absorption spectrophotometry with a graphite furnace. Clin Chem. 1978 Sep;24(9):1485–1490. [PubMed] [Google Scholar]
- Jacobs K., Shoemaker C., Rudersdorf R., Neill S. D., Kaufman R. J., Mufson A., Seehra J., Jones S. S., Hewick R., Fritsch E. F. Isolation and characterization of genomic and cDNA clones of human erythropoietin. 1985 Feb 28-Mar 6Nature. 313(6005):806–810. doi: 10.1038/313806a0. [DOI] [PubMed] [Google Scholar]
- Lin F. K., Suggs S., Lin C. H., Browne J. K., Smalling R., Egrie J. C., Chen K. K., Fox G. M., Martin F., Stabinsky Z. Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7580–7584. doi: 10.1073/pnas.82.22.7580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Livio M., Gotti E., Marchesi D., Mecca G., Remuzzi G., de Gaetano G. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet. 1982 Nov 6;2(8306):1013–1015. doi: 10.1016/s0140-6736(82)90050-2. [DOI] [PubMed] [Google Scholar]
- Neff M. S., Kim K. E., Persoff M., Onesti G., Swartz C. Hemodynamics of uremic anemia. Circulation. 1971 Jun;43(6):876–883. doi: 10.1161/01.cir.43.6.876. [DOI] [PubMed] [Google Scholar]
- Simon P., Ang K. S., Tanquerel T., Allain P., Mauras Y. Surcharge tissulaire en aluminium chez les hémodialysés. Test à la desferrioxamine. Nouv Presse Med. 1982 Jan 23;11(3):209–209. [PubMed] [Google Scholar]
- Winearls C. G., Oliver D. O., Pippard M. J., Reid C., Downing M. R., Cotes P. M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986 Nov 22;2(8517):1175–1178. doi: 10.1016/s0140-6736(86)92192-6. [DOI] [PubMed] [Google Scholar]